LABSCO, the leading specialty sales agent of innovative laboratory technologies and products to hospitals, physician office laboratories and alternate healthcare settings, has amended distributorship agreement with Sysmex America, a trusted world leader in clinical laboratory systemization and solutions. This agreement is for Sysmex reagents, controls and instruments including the Sysmex XS-1000i, Sysmex pocH-100i, Sysmex XP-300, XT-Series and XN-Series Automated Hematology Analyzers.
The agreement is effective immediately and continues until August 31, 2017. This agreement is exclusive in under 150 bed hospitals in the contiguous 48 states and non-exclusive in the physician office laboratory market.
"Sysmex America has enjoyed a successful, long-standing relationship with LABSCO built on trust, confidence and collaboration. LABSCO's clinical lab and instrumentation expertise/representation and focus on under 150 bed hospitals, physician office laboratories and regional reference lab markets will serve Sysmex America well, as we continue to meet the needs of our customers," said Rob Blackmore, director, distributor sales, Sysmex America, Inc.
"LABSCO is all about delivering superior diagnostics to provide better outcomes for our customers and Sysmex has been a long standing partner for us in meeting our purpose. We are excited to extend and strengthen our partnership with Sysmex as we believe they have best in class technology and service," said Joel Weihe, exec VP marketing and corp development, LABSCO. "Sysmex America offers a variety of products to a wide range of segments within the healthcare industry. In order to reach all customers in the United States, Latin America and Canada, the company partners with a network of distributors who are experts in their respective areas."
LABSCO is all about delivering superior diagnostics to provide better outcomes for its customers and partners. Focused on the under 150 bed hospitals, physician office laboratories and regional reference lab markets; LABSCO specializes in helping its customers improve outcomes with solutions that enhance clinical utility, operational efficiency and financial performance.
LABSCO is a market leader representing innovative diagnostic technologies and products for our partners and customers across the United States and is unique in that we serve as: An exclusive sales agent with best-in-class diagnostic technologies; A specialty distributor for market-leading brands of ancillary capital equipment; A general distributor of private label and key brand partner supplies.
Founded in 1991, Frazier Healthcare is a leading provider of growth buyout and venture capital to emerging healthcare service and biopharma companies. With over $2 billion under management across seven funds, Frazier Healthcare has invested in more than 150 companies across the entire developmental spectrum.
Sysmex America, Inc., in Lincolnshire, Illinois, the US headquarters of Sysmex Corporation (Kobe, Japan), is a trusted world leader in clinical laboratory systemization and solutions that optimize the clinical utility, operational efficiency and financial performance of the lab.